The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

PHASE3Active, not recruitingINTERVENTIONAL

Enrollment

137

Participants

Timeline

Start Date

October 25, 2024

Primary Completion Date

May 28, 2025

Study Completion Date

September 30, 2025

Conditions

Type 2 Diabetes

Interventions

DRUG

Noiiglutide Injection

Experimental group

DRUG

Noiiglutide Placebo

Placebo Comparator group

Trial Locations (1)

Beijing Chaoyang Hospital Affiliated to Capital, Beijing

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY